2.31

1.76% 0.04

After Hours: 2.42 0.11 +4.76%

Mdxhealth Sa (MDXH)

Overview News Price History Discussions Forecast

Mdxhealth Sa stock is traded at $2.31, with a volume of 183.86K. It is up +1.76% in the last 24 hours and down -27.81% over the past month. MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.

Previous Close:

$2.27

Open:

$2.31

24h Volume:

183.86K

Relative Volume:

1.10

Market Cap:

$118.65M

Revenue:

$107.88M

Net Income/Loss:

$-33.52M

P/E Ratio:

-3.4436

EPS:

-0.6708

Net Cash Flow:

$-11.94M

1W Performance:

+12.68%

1M Performance:

-27.81%

6M Performance:

-46.28%

1Y Performance:

+44.38%

1-Day Range:

$2.2473

$2.36

1-Week Range:

$2.00

$2.36

52-Week Range:

$1.51

$5.33

Mdxhealth Sa Stock (MDXH) Company Profile

Name

Mdxhealth Sa

Sector

Healthcare (1112)

Industry

Diagnostics & Research (52)

Phone

Address

Employee

364

Twitter

Next Earnings Date

2024-11-06

Latest SEC Filings

MDXH's Discussions on Twitter

Compare MDXH vs TMO, DHR, IDXX, A, WAT

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
MDXH Mdxhealth Sa	2.31	116.60M	107.88M	-33.52M	-11.94M	-0.6708
TMO Thermo Fisher Scientific Inc	531.67	195.93B	44.56B	6.72B	6.29B	17.74
DHR Danaher Corp	198.14	140.56B	24.57B	3.60B	5.26B	5.051
IDXX Idexx Laboratories Inc	580.76	46.39B	4.30B	1.06B	1.04B	13.08
A Agilent Technologies Inc	119.77	34.02B	7.07B	1.29B	993.00M	4.5355
WAT Waters Corp	326.20	32.49B	3.17B	642.63M	516.49M	10.77

Mdxhealth Sa Stock (MDXH) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jul-17-25	Initiated	Craig Hallum	Buy
Oct-31-24	Initiated	Lake Street	Buy
May-31-23	Initiated	TD Cowen	Outperform
Jul-18-22	Resumed	Oppenheimer	Outperform

Mdxhealth Sa Stock (MDXH) Latest News

Apr 13, 2026

MDxHealth (MDXH) director lists 4.7M indirect shares via managed funds - Stock Titan

Apr 13, 2026

MDxHealth (NASDAQ: MDXH) CCO reports multi-year share option grants - Stock Titan

Apr 13, 2026

MDxHealth (MDXH) CEO discloses 95,000 shares and extensive option grants - Stock Titan

Apr 13, 2026

MDxHealth (NASDAQ: MDXH) officer discloses extensive share option awards - Stock Titan

Apr 13, 2026

[Form 3] MDxHealth SA Initial Statement of Beneficial Ownership - Stock Titan

Apr 13, 2026

Buy Signal: Will MDxHealth SA benefit from green energy policies2026 Decliners & AI Driven Price Forecasts - baoquankhu1.vn

Apr 13, 2026

Short Interest in MDxHealth Surges 88.5% - National Today

Apr 13, 2026

Apr 10, 2026

MDxHealth (MDXH) director Don Hardison reports 40,000 share options - Stock Titan

Apr 10, 2026

Apr 09, 2026

MDxHealth (MDXH) director Siegel holds options for 10,000 ordinary shares - Stock Titan

Apr 09, 2026

MDxHealth (MDXH) director lists multi-year share option awards - Stock Titan

Apr 09, 2026

MDxHealth (NASDAQ: MDXH) director Koen Hoffman details 43,000 share options - Stock Titan

Apr 09, 2026

Apr 04, 2026

MDXH Technical Analysis & Stock Price Forecast - Intellectia AI

Apr 04, 2026

Health Catalyst (NASDAQ:HCAT) and MDxHealth (NASDAQ:MDXH) Head to Head Review - Defense World

Apr 04, 2026

Apr 02, 2026

MDxHealth (NASDAQ: MDXH) highlights losses, debt covenants and risk factors - Stock Titan

Apr 02, 2026

MDxHealth SA (NASDAQ:MDXH) Sees Significant Increase in Short Interest - marketbeat.com

Mar 26, 2026

Mar 20, 2026

MDXH Stock News Today | Earnings, Events & Price Alerts - Intellectia AI

Mar 20, 2026

Mar 19, 2026

MDXH: William Blair to Host Virtual Meeting on March 19 - GuruFocus

Mar 19, 2026

Mar 18, 2026

MDxHealth (NASDAQ: MDXH) director reports 10,000-share option grant - Stock Titan

Mar 18, 2026

MVM Partners (MDXH) discloses indirect stake of 4.7M MDxHealth shares - Stock Titan

Mar 18, 2026

MDxHealth SA (NASDAQ:MDXH) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat

Mar 18, 2026

Mar 17, 2026

Mdxhealth Highlights Data from Oxford’s ProMPT Study Demonstrating the Genomic Prostate Score GPS Test Predicts Adverse Outcomes Across Multiple Treatment Settings at EAU 2026 - The Manila Times

Mar 17, 2026

Mar 16, 2026

Gene test flags prostate cancer patients who may avoid aggressive treatment - Stock Titan

Mar 16, 2026

Mar 14, 2026

MDxHealth SA (NASDAQ:MDXH) Short Interest Update - MarketBeat

Mar 14, 2026

Mar 13, 2026

MDxHealth SA Stock (ISIN: US55278X1072) Gains Momentum on Prostate Cancer Test Momentum - AD HOC NEWS

Mar 13, 2026

Mar 06, 2026

Mdxhealth Earnings Call Highlights Fast Growth, Rising Costs - TipRanks

Mar 06, 2026

MDxHealth Completes Bio Techne ExoDx Acquisition to Bolster Precision Diagnostics - MSN

Mar 06, 2026

How is MDxHealth SA managing supply chain issuesJuly 2025 Recap & Low Drawdown Investment Strategies - baoquankhu1.vn

Mar 06, 2026

Mar 04, 2026

MDXHMdxhealth Sa Latest Stock News & Market Updates - Stock Titan

Mar 04, 2026

BTIG reiterates MDxHealth stock rating on strong volume growth By Investing.com - Investing.com Canada

Mar 04, 2026

BTIG reiterates MDxHealth stock rating on strong volume growth - Investing.com

Mar 04, 2026